MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) (formerly Advancis) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook currently markets KEFLEX®, the immediate-release brand of cephalexin, and MOXATAG® – the first and only FDA-approved once-daily amoxicillin.
View Top Employees from MiddleBrook Pharmaceuticals, IncWebsite | http://www.middlebrookpharma.com |
Revenue | $9.6 million |
Employees | 28 (20 on RocketReach) |
Founded | 2000 |
Address | 7 Village Circle Suite 100, Westlake, Texas 76262, US |
Phone | (301) 944-6600 |
Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceuticals, Manufacturing, Anti-Infective Products, Antibiotics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 325412 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular MiddleBrook Pharmaceuticals, Inc employee's phone or email?
The MiddleBrook Pharmaceuticals, Inc annual revenue was $9.6 million in 2024.
Sonya Sharp-Stenken is the Vice President, Managed Markets of MiddleBrook Pharmaceuticals, Inc.
20 people are employed at MiddleBrook Pharmaceuticals, Inc.
MiddleBrook Pharmaceuticals, Inc is based in Westlake, Texas.
The NAICS codes for MiddleBrook Pharmaceuticals, Inc are [325, 325412, 32541, 3254, 32].
The SIC codes for MiddleBrook Pharmaceuticals, Inc are [28, 283].